One step closer to identifying patients predisposed to treatment-resistant prostate cancer
Study highlights need for new treatment approaches
Researchers identify complex cascade of events, a “metabolic switch”
Future biomarker test could guide treatment, surveillance decisions
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Fine-tuning anti-androgen therapy shows promising results
D4A produces better anti-tumor results than parent compound
Research grants support ‘game-changing’ diagnosis and treatment projects